Table 1.
Demographic and clinical measurements for the participant cohort.
| Variable | All | By baseline HbA1c |
||
|---|---|---|---|---|
| HbA1c < 5·7% | 5·7% ≤ HbA1c ≤ 6·4% | HbA1c > 6·4% | ||
| Number of participants | 119 | 35 | 49 | 35 |
| Age | 54·4 ± 12·1 | 49.7 ± 12.9 | 55.9 ± 9.8 | 57.1 ± 13.1 |
| Gender | 93 Female 26 Male |
25 Female 10 Male |
44 Female 5 Male |
24 Female 11 Male |
| BMI (kg/m2) | 31·2 ± 5·5 | 30.6 ± 5·0 | 30.2 ± 5·4 | 33.1 ± 5·9 |
| Waist circumference (cm) | 100·4 ± 12·5 | 99.7 ± 11.1 | 97.8 ± 13.2 | 104.8 ± 11.8 |
| Hispanic/Latino ethnicity |
104 (87.4%) | 33 (94.3%) | 43 (87.8%) | 28 (80%) |
| Born in Mexico | 99 (83.2%) | 32 (91.4%) | 41 (83.7%) | 26 (74.3%) |
| HbA1c (%) | 6.3 ± 1.1 | 5·4 ± 0.2 | 6.0 ± 0.2 | 7.6 ± 1.3 |
| On medication* | 29 | 2 - 2 Metformin |
4 - 4 Metformin - 1 DPP-4 |
23 - 19 Metformin - 5 Sulphonylurea - 4 SGLT2 - 1 DPP-4 - 1 GLP1-RA |
Values for age, BMI, waist circumference, and HbA1c reported as mean ± SD.
T2D: Type 2 diabetes, BMI: Body mass index, SGLT2: Sodium-glucose co-transporter-2, DPP-4: Dipeptidyl peptidase 4, GLP1-RA: Glucagon-like peptide-1 receptor agonists.
*Some participants are on only one type of medication while others are on multiple types of medication.